Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06203652
Status:
RECRUITING
Last Update Posted:
2024-01-12
First Post:
2024-01-02
Brief Title:
The Pathogenesis and Prognostic Factors of Lymphoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Study Overview
Official Title:
The Pathogenesis and Prognostic Factors of Lymphoma
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients and to explore the relationship between those characteristics and phatogenesis
Detailed Description:
Lymphoma is a highly common malignant tumor in Asia This study aims to observe and describe the clinical and genetic charateristics of Chinese lymphoma patients and to explore the relationship between those charateristics and pathogenesis and prognostic factors in the real-world population This study is a non-interventional real world observational study and all registered data are collected from real clinical practice cases The medical data includes patient demographic tumor characteristics laboratory examination history of treatments adverse reactions efficacy results and possible prognostic factors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None